BCL-6 oncoprotein in breast cancer: Loss of expression in disease progression

Pathobiology

Volumn 76, Issue 5, 2009, Pages 235-242

  Pinto, António E ^a   André, Saudade ^a   Silva, Giovani ^c   Vieira, Sara ^b   Santos, Ana C ^d   Dias, Sérgio ^b   Soares, Jorge ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b Centro Hospitalar de Entre O Douro e Vouga   (Portugal)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

BCL 6 oncoprotein; Breast cancer; Immunohistochemistry; Prognosis; RT PCR

Indexed keywords

AZACITIDINE; BETA3 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; PROTEIN BCL 6; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; DEMETHYLATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; METHYLATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA3; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 70449119242     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228899     Document Type: Article

References (24)

1. Ye BH, Rao PH, Chaganti RS, Dalla-Favera R: Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993; 53: 2732-2735.
2. Ye BH, Lista F, LoCoco F, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R: Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993; 262: 747-750.
3. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS, Dalla-Favera R: BCL-6 protein is expressed in germinal-center B cells. Blood 1995; 86: 45-53.
4. Wagner SD, Kaeda JS: BCL-6: Rearrangement and mutation in lymphoma. Methods Mol Med 2005; 115: 251-270.
5. Pasqualluci L, Bereschenko O, Niu H, Klein U, Basso K, Guglielmino R, Cattoretti G, Dalla-Favera R: Molecular pathogenesis of non-Hodgkin's lymphoma: The role of Bcl-6. Leuk Lymphoma 2003; 44(suppl 3):S5-S12.
6. Phan RT, Dalla-Favera R: The BCL-6 protooncogene suppresses p53 expression in germinal- centre B cells. Nature 2004; 432: 635-639.
7. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R: BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nature Immunol 2005; 6: 1054-1060.
8. Kusam S, Vasanwala FH, Dent AL: Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function. Oncogene 2004; 23: 839-844.
9. Bos R, van Diest PJ, van der Groep P, Greijer AE, Hermsen MAJA, Heijnen I, Meijer GA, Baak JPA, Pinedo HM, van der Wall E, Shvarts A: Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D 1 and hypoxia- inducible factor-1- (HIF-1- ). Oncogene 2003; 22: 8948-8961.
10. Winter JN, Weller EA, Horning SJ, Krajewska M, Variakojis D, Habermann TM, Fisher RI, Kurtin PJ, Macon WR, Chhanabhai M, Felgar RE, His ED, Medeiros LJ, Wieck JK, Reed JC, Gascoyne RD: Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: A prospective correlative study. Blood 2006; 107: 4207-4213.
11. Lossos IS, Jones CD, Warncke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R: Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001; 98: 945-951.
12. Vitolo U, Botto B, Capello D, Vivenza D, Zagonel V, Gloghini A, Novero D, Parvis G, Calvi R, Ariatti C, Milan I, Bertini M, Boccomini C, Freilone R, Pregno P, Orsucci L, Palestro G, Saglio G, Carbone A, Gallo E, Guidano G: Point mutations of the BCL-6 gene: Clinical and prognostic correlation in B-diffuse large cell lymphoma. Leukemia 2002; 16: 268-275.
13. Sobin LH, Wittekind CH (eds): UICC TNM Classification of Malignant Tumours, ed 6. New York, John Wiley and Sons, 2002.
14. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
15. Pinto AE, André S, Soares J: Short term significance of DNA ploidy and cell proliferation in breast carcinoma: A multivariate analysis of prognostic markers in a series of 308 patients. J Clin Pathol 1999; 52: 604-611.
16. Logarajah S, Hunter P, Kraman M, Steele D, Lakhani S, Bobrow L, Venkitaraman A, Wagner S: BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene 2003; 22: 5572-5578.
17. Gygi SP, Rochon Y, Franza BR, Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19: 1720-1730.
18. Celis JE, Kruhoffer M, Gromova I, Frederiksen C, Ostergaard M, Thykjaer T, Gromov P, Yu J, Palsdottir H, Magnusson N, Orntoft TF: Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett 2000; 480: 2-16.
19. Munot K, Bell SM, Lane S, Horgan K, Hanby AM, Speirs V: Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol 2006; 37: 989-999.
20. Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 2005; 11: 2156-2162. (Pubitemid 40490172)
21. Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ, Lahti-Domenici J, Polyak K, Sacchi N, Garrett-Mayer E, Argani P, Sukumar S: Very high frequency of hypermethylated genes in breast cancer metastasis to bone, brain and lung. Clin Cancer Res 2004; 10: 3104-3109.
22. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
23. Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ: The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Int J Cancer 2006; 119: 1519-1529. (Pubitemid 44258756)
24. Engl T, Relja B, Marian D, Blumenberg C, Muller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D, Blaheta RA: CXCR4 chemokine receptor mediates prostate tumor cell adhesion through- 5 and- 3 integrins. Neoplasia 2006; 8: 290-301.